Details for New Drug Application (NDA): 076274
✉ Email this page to a colleague
The generic ingredient in CLOPIDOGREL BISULFATE is clopidogrel bisulfate. There are fifty-four drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clopidogrel bisulfate profile page.
Summary for 076274
| Tradename: | CLOPIDOGREL BISULFATE |
| Applicant: | Apotex Inc |
| Ingredient: | clopidogrel bisulfate |
| Patents: | 0 |
Pharmacology for NDA: 076274
| Mechanism of Action | Cytochrome P450 2C8 Inhibitors P2Y12 Receptor Antagonists |
| Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 076274
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 076274 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8014 | 0615-8014-05 | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-8014-05) |
| CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 076274 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8014 | 0615-8014-07 | 7 TABLET, FILM COATED in 1 BLISTER PACK (0615-8014-07) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | May 17, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 300MG BASE | ||||
| Approval Date: | Mar 4, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
